Pascal Leblanc (P Leblanc)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Patient Reported

Ejection Fraction

Transcription Factor

Top Venues

Cellular and molecular life sciences : CMLS

International journal of molecular sciences

Pathogens (Basel, Switzerland)

CNRS Délégation Rhône-Auvergne

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CNRS Délégation Rhône-Auvergne

France

Principal Investigator (CR1, HDR) :: Neuromuscular disorders / UMR5310 - INSERM U1217 INMG

Publications

Silvia Alboni, Valentina Secco, Bianca Papotti, Antonietta Vilella, Maria Pia Adorni, Francesca Zimetti, Laurent Schaeffer, Fabio Tascedda, Michele Zoli, Pascal Leblanc, Erica Villa
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACE hi Cells. Pathogens (Basel, Switzerland) 12 (5) (2023)
L Coudert, Alexis Osseni, Yann-Gaël Gangloff, Laurent Schaeffer, Pascal Leblanc
The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways. BMC biology 19 (1) (2021)
Emilien Bernard, Antoine Pegat, Juliette Svahn, Françoise Bouhour, Pascal Leblanc, Stéphanie Millecamps, Stéphane Thobois, Claire Guissart, Serge Lumbroso, Kevin Mouzat
Clinical and Molecular Landscape of ALS Patients with SOD1 Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study. International journal of molecular sciences 21 (18) (2020)
Laurent Coudert, Takashi Nonaka, Emilien Bernard, Masato Hasegawa, Laurent Schaeffer, Pascal Leblanc
Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models. Cellular and molecular life sciences : CMLS 76 (13) (2019)